What Does Evolus Do?

Total employees402
HeadquartersNewport Beach
Founded2014

Evolus (NASDAQ: EOLS) is a performance beauty company with a customer-centric approach focused on delivering impactful innovation. The company's lead product is Jeuveau® (prabotulinumtoxinA-xvfs), a proprietary 900 kilodalton (kDa) purified botulinum toxin type A neurotoxin approved for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. Evolus is focused on building a portfolio of differentiated products in aesthetics, with a current emphasis on expanding the market for Jeuveau® and developing its 'extra-strength' Nuceiva® (the brand name for Jeuveau in Europe and Canada) and its EvolFlex™ 'smart toxin' platform.

Where Is Evolus's Headquarters?

Evolus officeEvolus officeEvolus officeEvolus office
*Images sourced via web search. Rights belong to original owners

HQ Function

Serves as the central hub for corporate strategy, research and development, marketing, financial operations, and overall global management of Evolus's medical aesthetics business.

Notable Features:

Modern office facilities located in Newport Center, a prominent business district known for Class A office spaces, likely featuring collaborative workspaces and technology to support a dynamic workforce.

Work Culture:

Characterized by innovation, a fast-paced environment driven by the 'performance beauty' ethos, collaboration across departments, and a strong focus on scientific advancement and customer (healthcare provider and consumer) satisfaction.

HQ Significance:

Key decision-making center for a publicly traded company (NASDAQ: EOLS) competing in the rapidly growing global medical aesthetics market, particularly for its flagship neurotoxin product, Jeuveau®.

Values Reflected in HQ: The headquarters likely reflects values such as transparency (for a public company), innovation (R&D, marketing), and performance, aiming for an efficient and inspiring work environment.

Location:

Evolus supports functions globally including sales, marketing, medical affairs, regulatory compliance, and distribution partnerships. Key markets include the United States (with Jeuveau®) and an expanding presence in international markets such as Canada, Great Britain, Germany, Austria, and Italy with Nuceiva®. The company is actively pursuing further geographic expansion.

Street Address:

520 Newport Center Drive, Suite 1200

City:

Newport Beach

State/Province:

CA

Country:

USA

Where Else Does Evolus Operate Around the World?

London, United Kingdom

Address: Uncommon, 1 Long Lane, London, SE1 4PG, United Kingdom (for Evolus Limited)

To establish and grow Evolus's footprint in the European aesthetics market, manage commercialization of Nuceiva®, and engage with healthcare professionals and partners in the region.

Dublin, Ireland

Address: Registered address for Evolus International Limited (specific office details may vary)

Supports the expansion and operational management of Evolus's business across Europe and other international territories.

Buying Intent Signals for Evolus

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Evolus? Meet the Executive Team

As of April 2025, Evolus' leadership includes:

David Moatazedi - President and Chief Executive Officer
Sandra Beaver - Chief Financial Officer
Rui Avelar, M.D. - Chief Medical Officer and Head of R&D
Joe Gilliam - General Counsel & Chief Compliance Officer
Jeff PlomANN - Chief Commercial Officer, Nuceiva International
Tomoko Yamagishi-Dressler - Chief Marketing Officer
Michael Jafar - Chief Commercial Officer, Jeuveau U.S.

Who's Investing in Evolus?

Evolus has been backed by several prominent investors over the years, including:

The Vanguard Group, Inc.
BlackRock Inc.
Deep Track Capital, LP
Envoy Health Capital Management, LP
State Street Corporation

What Leadership Changes Has Evolus Seen Recently?

Hire1
Exits0

In the past 12 months, Evolus has strengthened its commercial leadership with a key new hire for its U.S. operations. No major C-suite departures have been publicly announced during this period for the current executive team.

New Appointments:

Michael Jafar, Michael Jafar joined Evolus as Chief Commercial Officer, Jeuveau U.S., bringing extensive experience in aesthetics and consumer brands to drive the company's U.S. commercial success.

What Technology (Tech Stack) Is Used byEvolus?

Discover the tools Evolus uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Evolus Email Formats and Examples

Evolus primarily uses the '[first_initial][last]@evolus.com' email format for its employees. This is a common pattern observed for the company.

[first_initial][last]@evolus.com

Format

jdoe@evolus.com

Example

85%

Success rate

What's the Latest News About Evolus?

Evolus, Inc. / Business Wire • May 7, 2024

Evolus Reports First Quarter 2024 Financial Results and Provides Business Update

Evolus announced record Q1 net revenue of $59.3 million, a 41% increase year-over-year, driven by strong Jeuveau® sales and customer growth. The company reiterated its 2024 net revenue guidance and highlighted progress in international expansion and its EvolFlex™ 'smart toxin' development program....more

Evolus, Inc. / Business Wire • February 1, 2024

Evolus Appoints Michael Jafar as Chief Commercial Officer, Jeuveau® U.S.

Evolus announced the appointment of Michael Jafar as Chief Commercial Officer, Jeuveau® U.S., effective February 5, 2024. Jafar brings over two decades of experience in aesthetics, consumer brands, and commercial leadership to drive the U.S. growth strategy for Jeuveau®....more

Evolus, Inc. / Business Wire • April 2, 2024

Evolus Announces Launch of Nuceiva® (Botulinum Toxin Type A) in Italy

Evolus announced the commercial launch of Nuceiva® (prabotulinumtoxinA-xvfs) in Italy, marking its fourth major European country launch. This expansion is part of Evolus's strategy to grow its international presence in the medical aesthetics market....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Evolus, are just a search away.